Rades D, Zwaan I, Schepers-von Ohlen D, Bohnet S, Janssen S, Koeck J
Cancers (Basel). 2025; 17(5).
PMID: 40075654
PMC: 11899581.
DOI: 10.3390/cancers17050807.
Song X, Liu J, Li H, Cai X, Li Z, Su Y
Cancers (Basel). 2023; 15(17).
PMID: 37686655
PMC: 10486879.
DOI: 10.3390/cancers15174377.
Prades-Sagarra E, Yaromina A, Dubois L
Cancers (Basel). 2023; 15(9).
PMID: 37173877
PMC: 10177176.
DOI: 10.3390/cancers15092412.
Rades D, Werner E, Glatzel E, Bohnet S, Schild S, Tvilsted S
Cancers (Basel). 2023; 15(2).
PMID: 36672276
PMC: 9856605.
DOI: 10.3390/cancers15020326.
Frerker B, Fiedler S, Kirschstein T, Lange F, Porath K, Sellmann T
Cells. 2023; 12(1).
PMID: 36611969
PMC: 9818134.
DOI: 10.3390/cells12010176.
Imaging features of toxicities associated with immune checkpoint inhibitors.
Gosangi B, McIntosh L, Keraliya A, Irugu D, Baheti A, Khandelwal A
Eur J Radiol Open. 2022; 9:100434.
PMID: 35967881
PMC: 9372737.
DOI: 10.1016/j.ejro.2022.100434.
Pulmonary Lymphangitis Poses a Major Challenge for Radiologists in an Oncological Setting during the COVID-19 Pandemic.
Fusco R, Simonetti I, Ianniello S, Villanacci A, Grassi F, DellAversana F
J Pers Med. 2022; 12(4).
PMID: 35455740
PMC: 9024504.
DOI: 10.3390/jpm12040624.
Differentiation between immune checkpoint inhibitor-related and radiation pneumonitis in lung cancer by CT radiomics and machine learning.
Cheng J, Pan Y, Huang W, Huang K, Cui Y, Hong W
Med Phys. 2022; 49(3):1547-1558.
PMID: 35026041
PMC: 9306809.
DOI: 10.1002/mp.15451.
Imaging side effects and complications of chemotherapy and radiation therapy: a pictorial review from head to toe.
Albano D, Benenati M, Bruno A, Bruno F, Calandri M, Caruso D
Insights Imaging. 2021; 12(1):76.
PMID: 34114094
PMC: 8192650.
DOI: 10.1186/s13244-021-01017-2.
Radiation recall pneumonitis induced by PD-1/PD-L1 blockades: mechanisms and therapeutic implications.
Teng F, Li M, Yu J
BMC Med. 2020; 18(1):275.
PMID: 32943072
PMC: 7499987.
DOI: 10.1186/s12916-020-01718-3.
Pneumonitis after radiotherapy for lung cancer (PARALUC): an interventional study to create a symptom-based scoring system for identification of patients developing radiation pneumonitis.
Rades D, Werner E, Glatzel E, Eggert M, Olbrich D, Tvilsted S
BMC Cancer. 2020; 20(1):785.
PMID: 32819311
PMC: 7441678.
DOI: 10.1186/s12885-020-07291-5.
Therapeutic effects of Co-Venenum Bufonis Oral Liquid on radiation-induced esophagitis in rats.
Li Y, Lin J, Xiao J, Li Z, Chen J, Wei L
Exp Anim. 2020; 69(3):354-362.
PMID: 32281552
PMC: 7445061.
DOI: 10.1538/expanim.19-0142.
Radiation-Induced Lung Injury: Assessment and Management.
Hanania A, Mainwaring W, Ghebre Y, Hanania N, Ludwig M
Chest. 2019; 156(1):150-162.
PMID: 30998908
PMC: 8097634.
DOI: 10.1016/j.chest.2019.03.033.
Development of single nanometer-sized ultrafine oxygen bubbles to overcome the hypoxia-induced resistance to radiation therapy via the suppression of hypoxia-inducible factor‑1α.
Iijima M, Gombodorj N, Tachibana Y, Tachibana K, Yokobori T, Honma K
Int J Oncol. 2018; 52(3):679-686.
PMID: 29393397
PMC: 5807044.
DOI: 10.3892/ijo.2018.4248.
Thoracic radiation-induced pleural effusion and risk factors in patients with lung cancer.
Zhao J, Day R, Jin J, Quint L, Williams H, Ferguson C
Oncotarget. 2017; 8(57):97623-97632.
PMID: 29228638
PMC: 5722590.
DOI: 10.18632/oncotarget.18824.
Independent test of a model to predict severe acute esophagitis.
Huang E, Robinson C, Molotievschi A, Bradley J, Deasy J, Oh J
Adv Radiat Oncol. 2017; 2(1):37-43.
PMID: 28740914
PMC: 5514225.
DOI: 10.1016/j.adro.2016.11.003.
Immunological Aspect of Radiation-Induced Pneumonitis, Current Treatment Strategies, and Future Prospects.
Kainthola A, Haritwal T, Tiwari M, Gupta N, Parvez S, Tiwari M
Front Immunol. 2017; 8:506.
PMID: 28512460
PMC: 5411429.
DOI: 10.3389/fimmu.2017.00506.
Standardized Herbal Formula PM014 Inhibits Radiation-Induced Pulmonary Inflammation in Mice.
Kim J, Shin D, Lee G, Kim J, Kim D, An Y
Sci Rep. 2017; 7:45001.
PMID: 28322297
PMC: 5359558.
DOI: 10.1038/srep45001.
Pneumonitis in Patients Treated With Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy.
Naidoo J, Wang X, Woo K, Iyriboz T, Halpenny D, Cunningham J
J Clin Oncol. 2016; 35(7):709-717.
PMID: 27646942
PMC: 5559901.
DOI: 10.1200/JCO.2016.68.2005.
Management of normal tissue toxicity associated with chemoradiation (primary skin, esophagus, and lung).
Yazbeck V, Villaruz L, Haley M, Socinski M
Cancer J. 2013; 19(3):231-7.
PMID: 23708070
PMC: 4836174.
DOI: 10.1097/PPO.0b013e31829453fb.
